ASTRAZENECA - IMFINZI PLUS TARLATAMAB SAFETY PROFILE CONSISTENT WITH INDIVIDUAL TREATMENTS, NO NEW SAFETY SIGNALS

Reuters · 1d ago

Please log in to view news